APA

Werle B., Kotzsch M., Lah T. T., Kos J., Gabrijelcic-Geiger D., Spiess E., Schirren J., Ebert W., Fiehn W., Luther T., Magdolen V., Schmitt M. & Harbeck N. (20050322). Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer. : Anticancer research.

Chicago

Werle B, Kotzsch M, Lah T T, Kos J, Gabrijelcic-Geiger D, Spiess E, Schirren J, Ebert W, Fiehn W, Luther T, Magdolen V, Schmitt M and Harbeck N. 20050322. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer. : Anticancer research.

Harvard

Werle B., Kotzsch M., Lah T. T., Kos J., Gabrijelcic-Geiger D., Spiess E., Schirren J., Ebert W., Fiehn W., Luther T., Magdolen V., Schmitt M. and Harbeck N. (20050322). Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer. : Anticancer research.

MLA

Werle B, Kotzsch M, Lah T T, Kos J, Gabrijelcic-Geiger D, Spiess E, Schirren J, Ebert W, Fiehn W, Luther T, Magdolen V, Schmitt M and Harbeck N. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer. : Anticancer research. 20050322.